July 2018 FDA Recall Dymista by Mylan Pharmaceuticals Inc.
D-1075-2018 - Presence of foreign substance

This Class II drug recall was voluntarily initiated by Mylan Pharmaceuticals Inc. on July 25, 2018 for the product Dymista. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1075-2018

Reason for Recall
Presence of foreign substance: Potential for glass in the neck area of the glass bottles.
Initiated
07-25-2018
Reported
08-15-2018
Quantity
20,780 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Mylan Pharmaceuticals Inc.
Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23 g net fill weight, Rx only, Manufactured by: Cipla Ltd., Goa, India, M.L.,, NDC 0037-0245-23

Batch or Lot Expiration Information

Lot# : GA70246, GA70254, Exp 02/2019

Affected Packages Involved in this Recall